Evidence map›Paper›PMID 27428484›Full record

ReviewCurrent opinion in pediatrics2016

Making a heart: advances in understanding the mechanisms of cardiac development.

Ellen Dees, H Scott Baldwin

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ellen DeesChildren's Hospital at Vanderbilt, Pediatric Heart Institute, Thomas P Graham Jr, Division of Pediatric Cardiology, Nashville, Tennessee, USA.
H Scott Baldwin
Monroe Carell Jr. Children's Hospital · US

Funding

Developmental Determinants of Cardiovascular DiseaseT32HL105334 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BALDWIN, H SCOTT · 2011 to 2021
$4.3M
Tie Tek Modulation of Cardiac DevelopmentR01HL118386 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BALDWIN, H SCOTT · 2013 to 2017
$2.1M
NHLBI NIH HHS R01 HL118386NHLBI NIH HHS T32 HL105334
6 · The paper itself

Abstract

purpose of reviewThe study of cardiac development is critical to inform management strategies for congenital and acquired heart disease. This review serves to highlight some of the advances in this field over the past year. RECENT

findingsThree main areas of study are included that have been particularly innovative and progressive. These include more precise gene targeting in animal models of disease and in moving from animal models to human disease, more precise in-vitro models including three-dimensional structuring and inclusion of hemodynamic components, and expanding the concepts of genetic regulation of heart development and disease. SUMMARY: Targeted genetics in animal models are able to make use of tissue and time-specific promotors that drive gene expression or knockout with high specificity. In-vitro models can recreate flow patterns in blood vessels and across cardiac valves. Noncoding RNAs, once thought to be of no consequence to gene transcription and translation, prove to be key regulators of genetic function in health and disease.

Indexed as

AnimalsDisease Models, AnimalDNA Copy Number VariationsGene Expression Regulation, DevelopmentalHeartHeart Defects, CongenitalHemodynamicsHumansIn Vitro TechniquesModels, AnatomicRNA, UntranslatedRNA, Untranslated

Identifiers

PMID27428484
PMCPMC6201235
OpenAlexW2490756317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.